Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 25, Pages 3817-3827
Publisher
American Society of Hematology
Online
2014-10-15
DOI
10.1182/blood-2014-07-587477
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Ex Vivo T Cell–Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission
- (2013) Ulas D. Bayraktar et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
- (2013) M. Schmidt-Hieber et al. BLOOD
- Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
- (2013) R. B. Walter et al. BLOOD
- Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update
- (2013) Bei Hu et al. Expert Review of Hematology
- Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning
- (2012) Daniel Weisdorf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparative Outcomes of Donor Graft CD34+Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
- (2012) Marcelo C. Pasquini et al. JOURNAL OF CLINICAL ONCOLOGY
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
- (2012) Claudio Anasetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303
- (2011) Steven M. Devine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study
- (2011) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
- (2011) R. J. Soiffer et al. BLOOD
- Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
- (2011) G. Socie et al. BLOOD
- Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
- (2010) Regis Peffault de Latour et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation
- (2010) Leo Luznik et al. IMMUNOLOGIC RESEARCH
- Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation
- (2010) Yu-Feng Lin et al. PEDIATRIC BLOOD & CANCER
- Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies
- (2009) J. N. Barker et al. BLOOD
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
- (2009) A. M. Alousi et al. BLOOD
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
- (2009) Jürgen Finke et al. LANCET ONCOLOGY
- Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
- (2009) M Brüggemann et al. LEUKEMIA
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
- (2008) Dimitri A. Breems et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now